Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

carotenoid/inflamació

L'enllaç es desa al porta-retalls
15 resultats

Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs or derivatives. 2. Description of the Relevant Art Recent studies have

Methods of modulating inflammation in preterm infants using carotenoids

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD The present disclosure relates to preterm infant formulas comprising lutein, lycopene, and beta-carotene, and the use of the preterm infant formulas to modulate inflammation, such as skin inflammation, in preterm infants. BACKGROUND OF THE DISCLOSURE Dietary carotenoids are lipid

Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BRIEF DESCRIPTION OF THE INVENTION This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in human nutraceuticals, pharmaceuticals and food supplements. This combination

Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for bovine health

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BRIEF DESCRIPTION OF THE INVENTION This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in bovine feed. This combination of nutritional supplements can contribute to

Use of carotenoids for producing drugs for the treatment of dermatoses

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION 1. Field of the Invention This application is a 371 of PCT/EP96/00381 filed on Feb. 2, 1996. The present invention relates to the use of carotenoids for producing drugs for the treatment of inflammatory disorders not caused by an infection with microorganisms or by the

Use of a reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE DISCLOSURE The present disclosure is directed to the use of reduced calorie infant formulas including nucleotides and/or carotenoids for reducing long term adverse health effects, including obesity, later in life. Also disclosed are reduced calorie, reduced protein infant formulas

Antioxidant compositions for treatment of inflammation or oxidative damage

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD The current invention, according to some embodiments, relates to methods of using antioxidant compositions to prevent, reduce, or eliminate the negative effects of oxidative damage or inflammation. In particular embodiments, the antioxidant compositions may be used with soft oral

Sea cucumber carotenoid lipid fraction products and methods of use

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION This patent relates to the general field of therapeutic products and methods to inhibit certain disease states related to the general medical field of human and veterinary pharmacology wherein the activation of the lipoxygenase pathways contribute to the pathological

Methods and compositions for treatment of macular and retinal disease

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION The present invention relates to methods and compositions for treatment and prevention of disease, and in particular embodiments, disorders of the eye. In an embodiment, the present invention describes linking therapeutic compounds to xanthophyll carotenoids to enhance
TECHNICAL FIELD The present application relates generally to dietary supplements and, more particularly, to dietary supplements containing a fullerene complex that may decrease multi-system symptoms of inflammation and aging in vivo. BACKGROUND The "old paradigm" of disease management reflects a

Fat-based food products

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE TO RELATED APPLICATIONS This application is a national phase application under 35 U.S.C. .sctn.371 that claims priority to PCT Application No. PCT/GB2012/053126 filed on Dec. 13, 2012, which claims the benefit of Great Britain Application No. 1121519.1 filed Dec. 14, 2011, both of

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE DISCLOSURE The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE DISCLOSURE The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE DISCLOSURE The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising

Pharmaceutical compositions and methods for protecting and treating sun damaged skin

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD This invention relates to pharmaceutical compositions, as well as methods, to protect skin from the armful effects of sunlight. BACKGROUND OF THE INVENTION The skin is the most environmentally-stressed organ in mammals, particularly in humans. Not only is the skin subjected to toxic
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge